Beitsch Peter D, Whitworth Pat W
Dallas Breast Center and Dallas Surgical Group, Dallas, TX, USA.
Ann Surg Oncol. 2014 Dec;21(13):4104-8. doi: 10.1245/s10434-014-3711-9. Epub 2014 Apr 23.
Whether breast cancer surgeons are adequately trained, skilled, and experienced to provide breast cancer genetic assessment, testing, and counseling came under debate in September 2013 when a major third-party payer excluded nongenetics specialists from ordering such testing. A literature search having failed to uncover any study on breast surgeons' skill and practice in this area, the American Society of Breast Surgeons (ASBrS) surveyed its members on their experience with the recognized crucial components of such testing.
In late 2013, ASBrS e-mailed a link to an online questionnaire to its U.S. members (n = 2,603) requesting a self-assessment of skills and experience in genetic assessment, testing, interpretation, and counseling. After approximately 6 weeks, the results were collated and evaluated.
By January 2, 2014, 907 responses (34.84 %) had arrived from breast surgeons nationwide working in academic settings (20 %), solo or small group private practice (39 %), large multispecialty groups (18 %), and other settings. More than half said they performed 3-generation pedigrees, ordered genetic testing, and provided pre- and posttest counseling. Most noted that they would welcome continuing educational support in genetics.
Currently the majority of breast surgeons provide genetic counseling and testing services to their patients. They report practices that meet or exceed recognized guidelines, including the necessary elements and processes for best practices in breast cancer genetics test counseling. Because breast cancer genetic testing is grossly underutilized relative to the size of the U.S. BRCA mutation carrier population, these appropriate services should not be restricted but rather supported and expanded.
2013年9月,当一家主要的第三方支付机构将非遗传学专家排除在这类检测的开单权限之外时,乳腺癌外科医生是否具备足够的培训、技能和经验来提供乳腺癌基因评估、检测及咨询服务引发了争论。由于文献检索未能找到任何关于乳腺外科医生在该领域的技能和实践的研究,美国乳腺外科医生协会(ASBrS)就其成员在这类检测的公认关键组成部分方面的经验开展了调查。
2013年末,ASBrS向其美国成员(n = 2603)发送了一份在线调查问卷的链接,要求他们对基因评估、检测、解读及咨询方面的技能和经验进行自我评估。大约6周后,对结果进行了整理和评估。
截至2014年1月2日,收到了来自全国范围内在学术机构工作(20%)、独立或小型私人诊所(39%)、大型多专科团体(18%)及其他机构工作的乳腺外科医生的907份回复(34.84%)。超过半数的人表示他们绘制了三代家系图、开了基因检测单并提供了检测前和检测后的咨询。大多数人指出他们欢迎在遗传学方面获得持续的教育支持。
目前,大多数乳腺外科医生为其患者提供基因咨询和检测服务。他们报告的实践符合或超过了公认的指南,包括乳腺癌基因检测咨询最佳实践的必要要素和流程。由于相对于美国BRCA突变携带者群体的规模而言,乳腺癌基因检测的利用率极低,这些适当的服务不应受到限制,而应得到支持和扩展。